Bengaluru, India

Madhavan Buddha

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Biocon Research Limited. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Madhavan Buddha: Innovator in Human Insulin Production

Introduction

Madhavan Buddha is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the production of human insulin. His innovative approach has the potential to enhance the purity and efficiency of insulin production, which is crucial for diabetes management.

Latest Patents

Madhavan Buddha holds a patent for the "Method of production of human insulin methyl ester." This invention relates to the enzymatic reaction used in the production of human insulin methyl ester. The patent also emphasizes the enhancement of purity in the final product, which is vital for therapeutic applications.

Career Highlights

Throughout his career, Madhavan has worked with prominent companies in the biotechnology sector. He has been associated with Biocon Research Limited and Biocon Biologics India Limited, where he has contributed to various research and development projects. His work has been instrumental in advancing the field of biologics.

Collaborations

Madhavan has collaborated with several professionals in his field, including Partha Hazra and Dinesh Channabasappa Goudar. These collaborations have fostered innovation and have led to significant advancements in the production of biopharmaceuticals.

Conclusion

Madhavan Buddha's contributions to the field of human insulin production highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the biotechnology industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…